Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe

Por um escritor misterioso
Last updated 22 dezembro 2024
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
The Lancet Commission on diagnostics: transforming access to diagnostics - The Lancet
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Making cough count in tuberculosis care
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Novel CRISPR-based detection of Leishmania species
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru - eClinicalMedicine
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Making cough count in tuberculosis care
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Validation and integration of rapid testing for COVID-19 and TB – Pai Global TB Group
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases in: The American Journal of Tropical Medicine and Hygiene Volume 107 Issue 2 (2022)
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Oral abstracts of the 11th IAS Conference on HIV Science, 18‐21 July 2021 - 2021 - Journal of the International AIDS Society - Wiley Online Library
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
The Lancet Microbe, June 2023, Volume 4, Issue 6, Pages e379-e480
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Real-time sewage surveillance for SARS-CoV-2 in Dhaka, Bangladesh versus clinical COVID-19 surveillance: a longitudinal environmental surveillance study (December, 2019–December, 2021) - The Lancet Microbe
Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a  cross-sectional, diagnostic accuracy study - The Lancet Microbe
Pathogens, Free Full-Text

© 2014-2024 fluidbit.co.ke. All rights reserved.